Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,824 stories, page 471 of 698

Advanced search

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

LTR Pharma secures national US manufacturing and fulfilment partner

BiotechDispatchOriginal source

🇨🇭Jul 21CDMObachem.comTier 2 · Direct publisher

Bachem plans to build a large-scale production facility in Sisslerfeld

Bachem PeptidesOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Fuso Pharmaceutical Industries,Ltd. – TSE:4538

TradingViewOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe's Crackdown Working? Viral Post Claims Jalebi Has Lost Its Bright Orange Colour

NDTV ProfitOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

World Pharmaceutical Lab Instruments - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

The Franklin NewsOriginal source

🌍Jul 21discoverynews.google.comTier 2 · Trade media

Understanding Agentic AI in Clinical Development

Fierce BiotechOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene: "TG-C U.S. Phase 3 Not a Failure... Investigating Unusually Strong Placebo Response" (Comprehensive)

아시아경제Original source

🇲🇽Jul 21Researchsecihti.mxTier 3 · Secondary coverage

Huellas de la ciencia: la Luna y los viajes al espacio

CONACYT NewsOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals Secures FDA QIDP Status and Expands Phase 3 Trial for RECCE® 327 Gel, Advancing Commercial Launch Plans

Kalkine MediaOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals Advances RECCE® 327 Toward Commercialisation With QIDP Designation and Phase 3 Indonesian Trial Expansion

KalkineOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

South Korea Eases Biosimilar Phase 3 Trial Rules

BusinesskoreaOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Gates Medical Research Institute and the Serum Institute of India reach agreement for the manufacture of M72/AS01E TB vaccine candidate, pending successful Phase 3 outcomes

European AIDS Treatment GroupOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals Expands MENA Reach with Exclusive Distribution Deal and Advances Diabetic Foot Infection Treatment to Phase 3

Kalkine MediaOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Recce Pharmaceuticals Secures Middle East Distribution Deal and Advances Diabetic Foot Infection Clinical Trial to Phase 3

KalkineOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

The stock price fell to the price limit on the news that Kolon TissueGene did not get the expected r..

매일경제Original source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

The first pharmaceutical company to deploy NVIDIA’s Vera Rubin has arrived! Drug development timelines could be shortened by 50%.

MoomooOriginal source

🌍Jul 21discoverynews.google.comTier 2 · Trade media

U.K. cabinet shuffle, Taiwan biotech and Biogen data — a BioCentury podcast

biocentury.comOriginal source

🌍Jul 21discoverynews.google.comTier 2 · Trade media

De-Risking a Rare Disease Launch Starts with Precision

Fierce BiotechOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Building a Transformative Career Across Academia, Advocacy, and Biotech - Karen Knudsen

UroTodayOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene: "US Phase 3 Trial of TG-C Is a Half-Success, Not a Failure"

아시아경제Original source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Mizuho reiterates Acadia stock rating on Alzheimer’s trial progress

Investing.com UKOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Rhode Island fugitive captured after 20 years was running biotech company in LA

NBC Los AngelesOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Biosimilar Phase 3 Waivers: A Boon for Big Pharma, a New Hurdle for Smaller Players

finance.biggo.comOriginal source

🌍Jul 21Industrymenicon.comTier 1 · Company source

Menicon launches a new knowledge platform to make trusted eye care information more accessible

MeniconOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Beyond Forecasting: How Synthetic Cohort Simulation Could Reshape Pharmaceutical Commercial Planning

HLTHOriginal source

🌍Jul 21discoverynews.google.comTier 3 · Aggregated media

Rhode Island fugitive captured after 20 years was running biotech company in LA

NBC Los AngelesOriginal source

🇸🇦Jul 21Regulatorysfda.gov.saTier 1 · Regulatory source

SFDA Suspends Registration of Drug Tavneos (avacopan)

The Saudi Food and Drug Authority (SFDA) has announced the suspension of the registration for the dr...

SFDA Saudi ArabiaOriginal source

🇺🇸Jul 21Regulatorysec.govTier 1 · Regulatory source

Novo Nordisk filed Form 6-K

SEC EDGAROriginal source

🇺🇸Jul 21Regulatorysec.govTier 1 · Regulatory source

Novartis filed Form 6-K

SEC EDGAROriginal source

🇫🇷Jul 21Industrysanofi.comTier 1 · Company source

2026 07 21 16 00 00 3330752

Sanofi evolves its Executive Committee to support its next strategic chapter Paris, July 21, 2026. S...

Sanofi NewsOriginal source

🇺🇸Jul 21Industrygilead.comTier 1 · Company source

Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy

Gilead SciencesOriginal source

🇺🇸Jul 21Industrygilead.comTier 1 · Company source

Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure

Gilead SciencesOriginal source

🇺🇸Jul 21Industrygilead.comTier 1 · Company source

Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Gilead SciencesOriginal source

🇺🇸Jul 21Regulatoryfederalregister.govTier 1 · Regulatory source

Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction

This document corrects typographical errors in the final rule that appeared in the May 20, 2026, Fed...

Federal RegisterOriginal source

🇺🇸Jul 21Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Federal RegisterOriginal source

🇺🇸Jul 21Regulatoryfederalregister.govTier 1 · Regulatory source

Expedited Investigational New Drug Pilot Program; Request for Information; Extension of the Comment Period

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice...

Federal RegisterOriginal source

🇺🇸Jul 21Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute of Neurological Disorders and Stroke; Notice of Meeting

Federal RegisterOriginal source

🇺🇸Jul 21Regulatoryfederalregister.govTier 1 · Regulatory source

Meeting of the Advisory Board on Radiation and Worker Health, Subcommittee for Procedure Reviews, National Institute for Occupational Safety and Health

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Preventio...

Federal RegisterOriginal source

🇺🇸Jul 21Regulatoryfederalregister.govTier 1 · Regulatory source

Recharter for the Advisory Commission on Childhood Vaccines

In accordance with the Federal Advisory Committee Act (FACA), the Department of Health and Human Ser...

Federal RegisterOriginal source

🇺🇸Jul 21Regulatoryfederalregister.govTier 1 · Regulatory source

Submission for Office of Management and Budget Review; Temporary Assistance for Needy Families (TANF) Financial Report, ACF-196T

The Administration for Children and Families (ACF) is requesting a 3-year extension of the Guidance...

Federal RegisterOriginal source

🌍Jul 21Regulatoryafro.who.intTier 1 · Regulatory source

Emergency21 July 2026 Feature StoryUganda safeguards essential health services during Ebola outbreak response

Kampala—At a health clinic in Arua, a border town in northern Uganda, staff are on high alert after...

WHO AFROOriginal source

🌍Jul 21Regulatoryafro.who.intTier 1 · Regulatory source

22 July 2026 News ReleaseMozambique launches Action Plan for Child Survival and reaffirms its commitment to reduce child mortality

Maputo – The Government of Mozambique, through the Ministry of Health, launched the Action Plan for...

WHO AFROOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: eribulin mesylate

Official structured record identifier: f57835e2-4c53-4e93-b54b-7d7a5000ae3d.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: DRx Choice DAYTIME COLD AND FLU

Official structured record identifier: 9ab47b10-b1ed-4ae1-94e8-09d50e952bb0.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: HYDROXYZINE HYDROCHLORIDE

Official structured record identifier: 87d4bbff-0498-4c26-86cb-7ce173afa0b6.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Armour Thyroid

Official structured record identifier: 7a44b924-7545-4809-98ac-da207e0881ae.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Estradiol

Official structured record identifier: 5718f042-e8c0-b721-e063-6294a90a5bef.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Buspirone Hydrochloride

Official structured record identifier: 5718bc19-07b2-b61d-e063-6394a90a6e80.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Betamethasone dipropionate

Official structured record identifier: 5718b3bd-77b3-8034-e063-6294a90af5e0.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: HTRCSW FUNGAL NAIL RENEWAL

Official structured record identifier: 523bc484-511c-b603-e063-6394a90a55ae.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ouamvh SKIN TAG REMOVER

Official structured record identifier: 50915164-112a-bf71-e063-6294a90a0754.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: BeamBalm ANTIFUNGAL CARE ESSENTIAL Oil

Official structured record identifier: 4ff57d2d-5e74-a995-e063-6394a90a3f9a.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: WERPEKA FUNGAL NAIL RENEWAL

Official structured record identifier: 4f7a8273-b7af-d532-e063-6394a90aa63a.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Gaayou Numbing

Official structured record identifier: 4c290118-7880-2a98-e063-6294a90a4c03.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Rstrvbr QUIT SMOKING

Official structured record identifier: 4a5e9691-727f-6bcd-e063-6294a90aadfc.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SANUSCODE WART REMOVER

Official structured record identifier: 4a0df8d0-d230-7c43-e063-6294a90a54bf.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SANUSCODE WART CORN REMOVER

Official structured record identifier: 4a0a7a7b-91e9-49f4-e063-6394a90a2462.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Bclsks NUMBING

Official structured record identifier: 49e26770-ddf6-7515-e063-6394a90a4ab3.

openFDA Drug LabelsOriginal source

🇺🇸Jul 21Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: DERMFREE FUNGI NAIL

Official structured record identifier: 49aba00d-9249-b403-e063-6394a90a787d.

openFDA Drug LabelsOriginal source